GLIMEPIRIDE Drug Patent Profile
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
When do Glimepiride patents expire, and when can generic versions of Glimepiride launch?
Glimepiride is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Carlsbad, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma Llc, Hikma Pharms, Indoco Remedies, Micro Labs, Mylan, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Teva, and Watson Labs. and is included in seventeen NDAs.
The generic ingredient in GLIMEPIRIDE is glimepiride. There are sixteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glimepiride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glimepiride
A generic version of GLIMEPIRIDE was approved as glimepiride by CHARTWELL MOLECULAR on October 6th, 2005.
Summary for GLIMEPIRIDE
Recent Clinical Trials for GLIMEPIRIDE
Identify potential brand extensions & 505(b)(2) entrants
|Peking University First Hospital||Phase 4|
|Jiangsu Province Geriatric Institute||Phase 4|
|Peking University People's Hospital||Phase 4|
Pharmacology for GLIMEPIRIDE
Anatomical Therapeutic Chemical (ATC) Classes for GLIMEPIRIDE
US Patents and Regulatory Information for GLIMEPIRIDE
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Prinston Inc||GLIMEPIRIDE||glimepiride||TABLET;ORAL||077370-002||Dec 23, 2005||AB||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Micro Labs||GLIMEPIRIDE||glimepiride||TABLET;ORAL||091220-005||Jun 29, 2012||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Ranbaxy Labs Ltd||GLIMEPIRIDE||glimepiride||TABLET;ORAL||076875-004||Oct 6, 2005||DISCN||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Ranbaxy||GLIMEPIRIDE||glimepiride||TABLET;ORAL||077366-002||Oct 6, 2005||DISCN||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|